Cytosorbents Corporation (CTSO) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Cytosorbents Corporation (CTSO) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $35.8M, listed on NASDAQ, employing roughly 149 people, carrying a beta of 1.44 to the broader market. Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Led by Phillip Chan, public since 2006-08-08.
Snapshot as of May 15, 2026.
- Spot Price
- $0.50
- ATM IV
- 32.1%
- IV Rank
- 3.5%
- IV Percentile
- 15.5%
- Term Structure Slope
- 0.018
As of May 15, 2026, Cytosorbents Corporation (CTSO) at-the-money implied volatility is 32.1%. IV rank is 3.5% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 15.5%. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
CTSO Strategy Selection at Current Volatility Levels
For Cytosorbents Corporation options at 32.1% ATM IV, low IV rank (3.5%) favors premium-buying or long-vol structures: long calls or puts, debit spreads, calendar spreads, long straddles. The risk: low-rank regimes can persist for months while time decay eats premium-buyers alive. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked CTSO volatility skew questions
- What is the current CTSO ATM implied volatility?
- As of May 15, 2026, Cytosorbents Corporation (CTSO) at-the-money implied volatility is 32.1%. IV rank is 3.5% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is CTSO IV high or low historically?
- IV is subdued relative to its 1-year history, conditions that typically favor premium-buying strategies (long calls, long puts, debit spreads, calendar spreads).
- What does CTSO volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.